Akeso, Inc. (AKESF)

12.10 -0.10 (-0.82%) USD  |  OTCM  |  Jun 09, 16:00
More

Akeso SG&A Expense (Quarterly)

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AKESF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2019 0.00
Date Value
September 30, 2018 0.00

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Ascletis Pharma, Inc. --
CStone Pharmaceuticals Co. Ltd. --
RemeGen Co., Ltd. 0.00
InnoCare Pharma Ltd. 23.46M
Adagene, Inc. --